305 related articles for article (PubMed ID: 16044315)
1. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Ozelo MC; Svirin P; Larina L
Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard-Soulier syndrome.
Hacihanefioglu A; Tarkun P; Gonullu E
Thromb Res; 2007; 120(3):455-7. PubMed ID: 17141823
[No Abstract] [Full Text] [Related]
3. Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
Tefre KL; Ingerslev J; Sørensen B
Haemophilia; 2009 Jan; 15(1):281-4. PubMed ID: 19149853
[TBL] [Abstract][Full Text] [Related]
4. Treatment of inherited platelet disorders.
Seligsohn U
Haemophilia; 2012 Jul; 18 Suppl 4():161-5. PubMed ID: 22726101
[TBL] [Abstract][Full Text] [Related]
5. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
[TBL] [Abstract][Full Text] [Related]
6. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
7. To general haemostasis--the evidence-based route.
Erhardtsen E
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():47-52. PubMed ID: 12214148
[TBL] [Abstract][Full Text] [Related]
8. Clinical Dilemma, Bernard Soulier Syndrome
J B; Patel NK; Kumar N; Singh J; Kumar K
Cardiovasc Hematol Disord Drug Targets; 2023; 23(1):72-75. PubMed ID: 37114784
[TBL] [Abstract][Full Text] [Related]
9. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
10. Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study.
Chuansumrit A; Wangruangsatid S; Lektrakul Y; Chua MN; Zeta Capeding MR; Bech OM;
Blood Coagul Fibrinolysis; 2005 Nov; 16(8):549-55. PubMed ID: 16269927
[TBL] [Abstract][Full Text] [Related]
11. Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection.
Chuansumrit A; Isarangkura P; Angchaisuksiri P; Sriudomporn N; Tanpowpong K; Hathirat P; Jorgensen LN
Haemophilia; 2000 Mar; 6(2):61-5. PubMed ID: 10781189
[TBL] [Abstract][Full Text] [Related]
12. Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.
Lee A; Maier CL; Batsuli G
Haemophilia; 2022 Jul; 28(4):633-641. PubMed ID: 35412688
[TBL] [Abstract][Full Text] [Related]
13. Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy).
Lanza F
Orphanet J Rare Dis; 2006 Nov; 1():46. PubMed ID: 17109744
[TBL] [Abstract][Full Text] [Related]
14. Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
Palsson R; Vidarsson B; Gudmundsdottir BR; Larsen OH; Ingerslev J; Sorensen B; Onundarson PT
Platelets; 2014; 25(5):357-62. PubMed ID: 23909788
[TBL] [Abstract][Full Text] [Related]
15. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.
Morfini M; Auerswald G; Kobelt RA; Rivolta GF; Rodriguez-Martorell J; Scaraggi FA; Altisent C; Blatny J; Borel-Derlon A; Rossi V
Haemophilia; 2007 Sep; 13(5):502-7. PubMed ID: 17880436
[TBL] [Abstract][Full Text] [Related]
17. A Novel Homozygous c.800C>G Substitution in GP1BA Exon 2 in a Kuwaiti Family with Bernard-Soulier Syndrome.
Shlebak A; Poles A; Manning R; Almuhareb S; De La Funte J; Mitchell M; Lucas G
Acta Haematol; 2015; 134(3):193-8. PubMed ID: 26044173
[TBL] [Abstract][Full Text] [Related]
18. Novel Bernard-Soulier syndrome variants caused by compound heterozygous mutations (case I) or a cytoplasmic tail truncation (case II) of GPIbα.
Yamamoto N; Akamatsu N; Sakuraba H; Matsuno K; Hosoya R; Nogami H; Kasahara K; Mitsuyama S; Arai M
Thromb Res; 2013 Apr; 131(4):e160-7. PubMed ID: 23414566
[TBL] [Abstract][Full Text] [Related]
19. Clinical phenotype in heterozygote and biallelic Bernard-Soulier syndrome--a case control study.
Bragadottir G; Birgisdottir ER; Gudmundsdottir BR; Hilmarsdottir B; Vidarsson B; Magnusson MK; Larsen OH; Sorensen B; Ingerslev J; Onundarson PT
Am J Hematol; 2015 Feb; 90(2):149-55. PubMed ID: 25370924
[TBL] [Abstract][Full Text] [Related]
20. Bernard-Soulier syndrome in pregnancy.
Prabu P; Parapia LA
Clin Lab Haematol; 2006 Jun; 28(3):198-201. PubMed ID: 16706937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
